Friday, August 12, 2016

Novartis in hot water over South Korea violations...

Swiss pharmaceutical giant Novartis risks seeing some of its medicines banned in South Korea after company executives were charged with offering illegal discounts to doctors, the Financial Times reported on Thursday.

According to the British business daily, South Korean prosecutors have asked the government to suspend the operations of Novartis Korea after six executives at the unit, including its president, were indicted for allegedly handing out $2.4-million (2.1-million euros) in illegal rebates from 2011 to 2016, in a move that could see the sale of implicated medicines banned for up to six months.

Novartis told AFP in an email that it would "take time to review the details of the indictment thoroughly and consider our next steps."

 "We have acknowledged and regret that certain associates in (South) Korea conducted small medical meetings and other scientific related activities through trade journals, in violation of our policies," it said. Full story...

Related posts:
  1. Italy suspends Novartis vaccine after three persons die...
  2. Drugs giant GlaxoSmithKline bribed doctors to boost sales...
  3. Top Novartis senior managers quit in Japan fraud scandal...
  4. Japan to file criminal action against Novartis...
  5. Novartis eye care unit hit by China bribery claims...
  6. Germany fourth country to ban Novartis flu vaccine...

No comments:

Post a Comment